Long-term survival outcomes and quality of life of image-guided proton therapy for operable stage I non-small cell lung cancer: A phase 2 study

Definitive radiation therapy (RT), especially stereotactic body RT (SBRT), is an important treatment option for stage I non-small cell lung cancer (NSCLC). Surgical resection is the first-line management for operable patients, with SBRT recommended for medically inoperable patients or those who refuse surgery [1]. A recent pooled randomized and propensity-matched prospective study reported that SBRT was comparable to surgery in operable patients [2]. As patient preferences diversify, offering effective non-surgical options in the treatment decision process holds considerable clinical value.

Source: Radiotherapy and Oncology - April 11, 2024 Category: Radiology Authors: Koichiro Nakajima, Masanosuke Oguri, Hiromitsu Iwata, Yukiko Hattori, Shingo Hashimoto, Kento Nomura, Kensuke Hayashi, Toshiyuki Toshito, Kenji Akita, Fumiya Baba, Hiroyuki Ogino, Akio Hiwatashi Tags: Original Article Source Type: research